-

11:15:37 AM

TOMDF Stock News

TOMDF - Todos Medical Ltd

10/21/21 10:18 AM

OTC : TOMDF

Todos Medical Announces Publication in Journal of Clinical Virology Highlighting Clinical Utility of cPass Semi-Quantitative Neutralizing Antibody Test in SARS-CoV-2 Risk Assessment Post-Vaccination or Recovery from Infection

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions

RHEA-AI

neutral

10/14/21 12:30 PM

OTC : TOMDF

Todos Medical to Conduct Webinar Highlighting the cPass SARS-COV-2 Neutralizing Antibody Test for AMDA, The Society for Post-Acute and Long-Term Care Medicine, on October 22, 2021 at 12:00 PM EDT

Dr. Jorge Leone, Chief Scientific Officer of Todos Medical, and Sean Taylor, North American FAS Manager of Genscript, will discuss the importance of the cPass™ SARS-COV-2 neutralizing antibody test as a “New Paradigm for Measuring Immunity in a Pre- and Post-Vaccination Era” AMDA’s 5,500 members

RHEA-AI

positive

10/06/21 11:00 AM

OTC : TOMDF

Todos Medical Announces Positive Data in Hospitalized and Outpatient Setting for TolloTest™, a Novel SARS-CoV-2 3CL Protease Biomarker Assay

Data demonstrated very high correlation with PCR ct values in positive patients Data demonstrated 100% sensitivity, as early as 1-3 days post-exposure, in identifying fully vaccinated asymptomatic patients infected with COVID-19 New York, NY, and Tel Aviv, ISRAEL, Oct. 06, 2021

RHEA-AI

neutral

10/05/21 6:00 AM

OTC : TOMDF

UPDATE - Todos Medical Announces October Conference Calendar

via NewMediaWire – Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it will be presenting at multiple industry conferences in October.

RHEA-AI

neutral

10/04/21 7:30 AM

OTC : TOMDF

clinical trialcovid-19

Todos Medical Provides Update on COVID-19 Oral Antiviral 3CL Protease (Main Protease) Inhibitor Tollovir Clinical Development Program in Light of Molnupiravir Clinical Trial Data from Merck

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today provided an update on its COVID-19 oral antiviral 3CL protease (“Main Protease”,

RHEA-AI

neutral

09/30/21 9:08 AM

OTC : TOMDF

Todos Medical Announces Positive Observational Trial Results for Oral Antiviral 3CL Protease (MPro) Inhibitor Tollovir®

RHEA-AI

neutral

09/28/21 9:09 AM

OTC : TOMDF

Todos Medical Announces October Conference Calendar

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it will be presenting at multiple industry conferences in

RHEA-AI

neutral

09/27/21 7:30 AM

OTC : TOMDF

Todos Medical Receives Approval by Amazon to Sell Immune Supplements Tollovid® & Tollovid Daily™

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company,

RHEA-AI

neutral

09/24/21 9:36 AM

OTC : TOMDF

earnings

Todos Medical Reports Second Quarter 2021 Financial Results

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions

RHEA-AI

neutral

09/24/21 9:01 AM

OTC : TOMDF

UPDATE: Todos Medical Announces 90-Day Moratorium on Conversions of Convertible Notes and Lockup of Common Stock Sales with Convertible Note Holders

Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has entered into an agreement with holders of the Company’s convertible notes

RHEA-AI

neutral